SCHEMBL16209717

SCHEMBL16209717

CCOC(=O)C(O)C1OC(=O)c2c(OC)cc(OC)cc21

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.44
▸ KDM4E B2RXH2 3/20 0.44
▸ CYP3A4 P08684 2/20 0.44
▸ TDP1 Q9NUW8 2/20 0.41
▸ ABCB1 P08183 4/20 0.39
▸ ALOX15 P16050 1/20 0.38
▸ SLC2A1 P11166 1/20 0.38
▸ MAPK1 P28482 2/20 0.37
▸ HPGD P15428 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ ABCG2 Q9UNQ0 1/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ TSHR P16473 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14965696 1.00 ALDH1A1 (0.44) ALDH1A1KDM4ECYP3A4TDP1ABCB1
SCHEMBL16218982 0.89 CNR2 (0.38) ALDH1A1KDM4ECYP3A4TDP1MAPK1
SCHEMBL14965915 0.83 KDM4E (0.44) ALDH1A1KDM4ECYP3A4HPGDHSD17B10
SCHEMBL16209393 0.83 KDM4E (0.44) ALDH1A1KDM4ECYP3A4HPGDHSD17B10
SCHEMBL14970291 0.81 SLC2A1 (0.46) ALDH1A1KDM4ECYP3A4ABCB1SLC2A1
SCHEMBL17182752 0.81 SLC2A1 (0.46) ALDH1A1KDM4ECYP3A4ABCB1SLC2A1
SCHEMBL14966093 0.81 CYP1A1 (0.48) ALDH1A1KDM4ETDP1MAPK1HPGD
SCHEMBL16209378 0.80 KDM4E (0.56) ALDH1A1KDM4EHPGDHSD17B10KMT2A
SCHEMBL14970274 0.80 KDM4E (0.56) ALDH1A1KDM4EHPGDHSD17B10KMT2A
SCHEMBL16209422 0.79 CYP3A4 (0.41) ALDH1A1KDM4ECYP3A4MAPK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9073887-B2 Single step enantioselective process for the preparation of 3-substituted chiral phthalides COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2015-07-07 — — US claimed
US-20140330027-A1 SINGLE STEP ENANTIOSELECTIVE PROCESS FOR THE PREPARATION OF 3-SUBSTITUTED CHIRAL PHTHALIDES COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2014-11-06 — — US claimed
US-9505733-B2 Single step enantioselective process for the preparation of 3-substituted chiral phthalides COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2016-11-29 — — US disclosed
US-20150299154-A1 SINGLE STEP ENANTIOSELECTIVE PROCESS FOR THE PREPARATION OF 3-SUBSTITUTED CHIRAL PHTHALIDES COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2015-10-22 — — US disclosed
US-9073887-B2 Single step enantioselective process for the preparation of 3-substituted chiral phthalides COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2015-07-07 — — US disclosed
US-20140330027-A1 SINGLE STEP ENANTIOSELECTIVE PROCESS FOR THE PREPARATION OF 3-SUBSTITUTED CHIRAL PHTHALIDES COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2014-11-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140330027-A1 SINGLE STEP ENANTIOSELECTIVE PROCESS FOR THE PREPARATION OF 3-SUBSTITUTED CHIRAL PHTHALIDES PPOX, NFE2L2, CBR1 ALDH1A1 406/4885KDM4E 805/4885CYP3A4 11/4885
US-20150299154-A1 SINGLE STEP ENANTIOSELECTIVE PROCESS FOR THE PREPARATION OF 3-SUBSTITUTED CHIRAL PHTHALIDES PPOX, NFE2L2, CBR1 ALDH1A1 406/4885KDM4E 805/4885CYP3A4 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback